Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$7.15 - $9.78 $13,685 - $18,718
1,914 Added 61.72%
5,015 $36,000
Q1 2023

May 15, 2023

SELL
$6.62 - $9.57 $847 - $1,224
-128 Reduced 3.96%
3,101 $24,000
Q4 2022

Feb 13, 2023

SELL
$8.78 - $12.47 $763 - $1,084
-87 Reduced 2.62%
3,229 $31,000
Q3 2022

Nov 14, 2022

BUY
$8.96 - $14.7 $29,711 - $48,745
3,316 New
3,316 $37,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.